Imipramine-fentanyl antinociception in a rabbit tooth pulp model

Area of Science:

• Pharmacology
• Neuroscience
• Pain Management

Background:

• Opioid analgesics are commonly used for pain management but are associated with significant side effects, including respiratory depression.
• Non-opioid analgesics with synergistic effects with opioids could offer improved pain relief with reduced adverse events.
• Imipramine, a tricyclic antidepressant, has shown analgesic properties, but its interaction with opioids requires further investigation.

Purpose of the Study:

• To evaluate the antinociceptive effects of imipramine (I) alone and in combination with fentanyl (F) in a rabbit model.
• To assess the potential synergistic interaction between imipramine and fentanyl on pain relief and respiratory function.
• To compare the antinociceptive efficacy of imipramine with morphine.

Main Methods:

• Electrically-induced lick-chew responses via tooth pulp stimulation were used to model nociception in rabbits.
• Dose-response curves were generated for intravenous injections of imipramine and morphine.
• Fentanyl's ED50 was determined after pretreatment with varying doses of imipramine, and combinations were analyzed using isobolography.

Main Results:

• Imipramine exhibited dose-dependent antinociception comparable to morphine, with an ED50 of 4.35 mg/kg.
• Imipramine pretreatment significantly increased fentanyl's potency in a dose-dependent manner (up to 34.4-fold increase).
• Combinations of imipramine and fentanyl demonstrated synergistic antinociceptive effects and prevented fentanyl-induced respiratory depression (PaCO2 increases).

Conclusions:

• Imipramine possesses significant antinociceptive properties and acts synergistically with fentanyl.
• The combination of imipramine and fentanyl offers a promising strategy for enhanced analgesia with reduced respiratory side effects.
• Further research into this combination could lead to improved pain management protocols.